Phio Pharmaceuticals
PHIO
#10279
Rank
S$14.64 M
Marketcap
S$1.33
Share price
-2.78%
Change (1 day)
-32.43%
Change (1 year)

Earnings for Phio Pharmaceuticals (PHIO)

Earnings in 2025 (TTM): -S$10.43 Million

According to Phio Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -S$9.04 Million, an increase over its 2023 earnings that were of -S$13.68 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Phio Pharmaceuticals from 2011 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$10.43 Million15.41%
2024 -S$9.04 Million-33.96%
2023 -S$13.68 Million-5.7%
2022 -S$14.51 Million-13.6%
2021 -S$16.79 Million51.09%
2020 -S$11.12 Million-1.28%
2019 -S$11.26 Million21.03%
2018 -S$9.3 Million-53.1%
2017 -S$19.83 Million74.49%
2016 -S$11.37 Million-12.02%
2015 -S$12.92 Million16.17%
2014 -S$11.12 Million-57.95%
2013 -S$26.44 Million62.45%
2012 -S$16.28 Million0.87%
2011 -S$16.14 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-S$0.21 Billion 1,905.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-S$22.94 Million 128.29%๐Ÿ‡บ๐Ÿ‡ธ USA